Abstract: The present invention relates to marzipan-like compositions comprising an anion exchange resin, almond paste, and preferably psyllium fiber, in unit dose form. This invention also relates to the use of these compositions in a method for treating hypercholesterolemia. The compositions are a convenient, portable, highly palatable, and well tolerated dosage form for administering anion exchange resin.
Abstract: Liquid antacid compositions for neutralizing stomach acid in humans and other animals comprising: an alkaline earth carbonate salt; and alkali metal phosphate salt; an alkali metal bicarbonate salt; and other excipients.
Type:
Grant
Filed:
October 3, 1994
Date of Patent:
March 12, 1996
Assignee:
The Procter & Gamble Company
Inventors:
Robert L. Wilson, Sara A. Ubelhor, William A. Cruz
Abstract: A process for reducing precipitation of difficultly soluble pharmaceutical active in a mixture of polyethylene glycol, polyvinylpyrrolidone and propylene glycol.
Abstract: Disclosed are oral compositions which are effective against plaque and gingivitis and contain a noncationic water insoluble antibacterial agent.
Abstract: Methods for manufacturing baking soda dentifrice compositions containing pyrophosphate tartar control agent using tetrasodium pyrophosphate. The process and compositions have less than about 20% of the pyrophosphate dissolved in the dentifrice composition.
Type:
Grant
Filed:
December 28, 1994
Date of Patent:
October 10, 1995
Assignee:
Procter & Gamble
Inventors:
Thomas E. Huetter, Donald J. White, Jr., Edward R. Cox, Cloyd Dixon, Jr.
Abstract: Polyphosphonic acid ester compounds with flavorant, coolant and/or sweetener components, and tartar, plaque and/or calculus control compositions with improved taste comprising one or more polyphosphonic acid ester compounds are described.
Abstract: Methods for aiding periodontal tissue regeneration with compositions containing bioresorbable polymers, leachable solvents, and bioavailable drug actives. The compositions useful for these methods are characterized by becoming harder upon contact with the periodontal tissue such that the composition is effective for aiding tissue regeneration and by releasing a therapeutically-effective amount of drug active agent.
Type:
Grant
Filed:
June 11, 1993
Date of Patent:
September 5, 1995
Assignee:
The Procter & Gamble Company
Inventors:
Nalinkant C. Damani, Douglas C. Mohl, Robert E. Singer, Jr.
Abstract: Psyllium husk comprising particle sizes distributed such that: less than about 15% is larger than about 80 mesh, at least about 45% is within the range of from about 80 mesh to about 200 mesh, and less than about 40% is smaller than about 200 mesh. In addition, psyllium-containing products for oral administration comprising small particle size psyllium husk according to the present invention are described.
Type:
Grant
Filed:
October 21, 1993
Date of Patent:
August 29, 1995
Assignee:
The Procter & Gamble Company
Inventors:
Paul D. Leis, Jr, Larry E. Burns, Karen R. Hafer
Abstract: Disclosed are oral compositions which are effective against plaque and gingivitis and contain a noncationic water insoluble antibacterial agent.
Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing an enzyme, a surfactant, a chelating agent, a fluoride ion source and wherein the pH of the composition is from about 4.0 to about below 6.0.
Type:
Grant
Filed:
March 3, 1994
Date of Patent:
August 1, 1995
Assignee:
The Procter & Gamble Company
Inventors:
Michael F. Lukacovic, Satyanarayana Majeti
Abstract: Oral compositions, such as oral gels, toothpastes and mouthwashes, containing an enzyme, a surfactant, a chelating agent and a fluoride ion source.
Type:
Grant
Filed:
March 3, 1994
Date of Patent:
July 11, 1995
Assignee:
The Procter & Gamble Company
Inventors:
Satyanarayana Majeti, Michael F. Lukacovic
Abstract: The present invention describes a product comprising least one pharmaceutically acceptable active in a mixture of a tri-ester and polyvinylpyrrolidone, and a process for producing the same. In further embodiments, the present invention also relates to a process for encapsulating the composition within soft gelatin shells. The resulting compositions and capsules provide an effective means for oral delivery of a wide variety of pharmaceutically acceptable actives.
Abstract: Agglomerated psyllium husk comprising edible acid uniformly dispersed throughout the agglomerating coating. Preferred are maltodextrin-containing agglomerates of psyllium husk comprising citric acid uniformly dispersed throughout the maltodextrin coating. This agglomerated psyllium husk has improved mixability and dispersibility in liquids.
Abstract: Stabilizer compositions including specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer, the partial salts containing from about 15% to about 40% free acid, are disclosed. The cationic salt function is from about 0.1% to about 9.9% zinc or strontium cations, and from about 20% to about 67% calcium cations of the total initial carboxyl groups are reacted. Also disclosed are denture stabilizing compositions including a safe and adhesively effective amount of two or more denture adhesive components where one of the denture adhesive components is the above mixed partial salt.
Type:
Grant
Filed:
April 15, 1994
Date of Patent:
June 13, 1995
Assignee:
The Proctor & Gamble Company
Inventors:
Jayanth Rajaiah, Bao K. Ha, Abel Saud, Bruce J. MacKay
Abstract: Psyllium husk-containing drink mix compositions comprising psyllium husk, an anion exchange resin, and edible, water soluble salts. The edible, water soluble salts are present at a level sufficient to reduce the gellation rate of the psyllium husk and anion exchange resin-containing composition when dispersed in an aqueous solution.
Abstract: A composition providing the physiologic sensations of ethanol, comprising an alkoxy glycol ether and preferably further comprising a cooling agent and an oral care or pharmaceutical active.
Abstract: The present invention relates to pharmaceutical compositions useful for treating or preventing gastrointestinal disorders. These compositions comprise a campylobacter-inhibiting antimicrobial agent such as nitrofurantoin and bismuth subsalicylate, and a histamine-2 receptor blocking anti-secretory agent such as cimetidine.The present invention further relates to methods for treating or preventing gastrointestinal disorders in humans or lower animals by administering a campylobacter-inhibiting antimicrobial agent and a histamine-2 receptor blocking anti-secretory agent.
Abstract: Concentrated mouthrinse, methods of use and methods of manufacturing the mouthrinse for efficient delivery of antimicrobials wherein the composition is concentrated and substantially free of non-cationic surfactants.